background
equin
influenza
ei
highli
contagi
diseas
caus
virus
subtyp
rapid
diagnosi
ei
essenti
reduc
diseas
spread
mani
rapid
antigen
detect
rad
test
diagnos
human
influenza
avail
abil
diagnos
ei
systemat
evalu
object
aim
studi
compar
perform
rad
test
diagnosi
ei
method
rad
test
perform
fivefold
serial
dilut
ei
viru
determin
detect
limit
four
sensit
rad
test
immunoac
flu
bd
flu
examan
quick
chaser
flu
b
esplin
influenza
bn
evalu
use
nasopharyng
sampl
collect
experiment
infect
natur
infect
hors
result
compar
obtain
use
molecular
test
detect
limit
rad
test
vari
huge
even
four
rad
test
show
best
sensit
less
sensit
molecular
techniqu
durat
viru
detect
experiment
infect
hors
shorter
use
rad
test
use
molecular
techniqu
rad
test
detect
realtim
rtpcrposit
sampl
natur
infect
hors
studi
demonstr
import
choos
right
rad
test
three
fit
diagnos
ei
also
indic
even
rad
test
highest
sensit
serv
adjunct
molecular
test
potenti
falseneg
result
equin
influenza
ei
caus
equin
influenza
viru
eiv
one
import
respiratori
diseas
hors
due
highli
contagi
natur
eiv
member
famili
orthomyxovirida
genu
influenza
viru
although
two
subtyp
eiv
recogn
virus
subtyp
isol
last
three
decad
may
extinct
contrast
virus
subtyp
major
caus
respiratori
diseas
hors
throughout
world
except
equin
popul
new
zealand
iceland
ei
never
record
hors
infect
eiv
exhibit
acut
onset
pyrexia
associ
depress
anorexia
nasal
discharg
cough
eiv
infect
occur
via
inhal
aerosol
viru
particl
way
human
season
influenza
presumpt
diagnosi
ei
made
group
suscept
hors
basi
rapid
spread
febril
diseas
frequent
cough
howev
clinic
sever
rapid
diseas
spread
depend
immun
statu
herd
difficult
distinguish
ei
vaccin
hors
acut
respiratori
diseas
exampl
equin
rhinopneumon
equin
viral
arter
equin
rhiniti
viru
infect
thu
laboratori
test
identifi
eiv
respiratori
tract
secret
detect
seroconvers
requir
make
definit
diagnosi
viru
isol
vi
tradit
gold
standard
diagnost
method
ei
replac
revers
transcriptas
polymeras
chain
reaction
rtpcr
realtim
rtpcr
rrtpcr
assay
superior
rapid
sensit
also
rapid
antigen
detect
rad
test
licens
diagnos
human
influenza
success
use
diagnosi
ei
rad
test
enabl
qualit
detect
influenza
viral
nucleoprotein
antigen
respiratori
specimen
without
technic
expertis
expens
equip
thu
often
use
initi
screen
test
ei
varieti
rad
test
commerci
avail
time
write
april
least
rad
test
commerci
avail
japan
diagnos
human
influenza
one
rad
kit
diagnosi
avian
influenza
prior
one
conduct
extens
comparison
sensit
rad
test
detect
eiv
evalu
sensit
select
rad
test
licens
japan
diagnosi
human
avian
influenza
detect
eiv
nasopharyng
swab
experiment
natur
infect
hors
virus
eiv
strain
propag
allanto
caviti
embryon
hen
egg
stock
viru
subject
lowspe
centrifug
g
min
remov
cell
debri
aliquot
store
use
stock
viru
titr
egg
infecti
dose
eid
ml
viru
challeng
carri
previous
describ
three
hors
inocul
inhal
eid
ml
head
day
nasopharyng
swab
jcb
industri
tokyo
japan
collect
daili
day
day
follow
collect
swab
place
ml
transport
medium
phosphatebuff
salin
supplement
wv
tryptos
phosphat
broth
unitsml
penicillin
lgml
streptomycin
lgml
amphotericin
b
nasopharyng
swab
transport
medium
subsequ
vortex
second
centrifug
g
min
supernat
aliquot
store
use
viru
isol
vi
conduct
previous
describ
experiment
protocol
approv
anim
care
committe
equin
research
institut
japan
race
associ
thirti
rrtpcrposit
nasopharyng
sampl
collect
ei
outbreak
ireland
analys
sampl
collect
hors
mix
vaccin
statu
varieti
premis
includ
polo
yard
n
three
race
yard
n
nonthoroughbr
yard
n
show
jump
yard
n
thoroughbr
stud
n
nonthoroughbr
stud
n
follow
sampl
collect
nasopharyng
swab
place
ml
transport
medium
rrtpcr
carri
previous
describ
thirti
rrtpcrneg
nasopharyng
sampl
also
collect
racehors
japan
rad
test
includ
studi
purchas
commerci
tabl
rad
test
licens
diagnosi
human
avian
influenza
esplin
influenza
japan
test
conduct
accord
manufactur
instruct
initi
test
determin
detect
limit
rad
conduct
duplic
use
fivefold
serial
dilut
viru
stock
transport
medium
evalu
conduct
rad
test
lowest
limit
detect
use
nasopharyng
swab
collect
experiment
infect
natur
infect
hors
result
judg
two
oper
posit
band
visibl
examin
approx
cm
eye
sampl
assign
score
posit
posit
band
visibl
examin
sampl
deem
neg
case
judgement
split
sampl
assign
detect
limit
express
minimum
viru
titr
eid
ml
posit
reaction
rtpcr
primer
hemagglutinin
ha
gene
conduct
use
qiagen
onestep
rtpcr
kit
qiagen
tokyo
japan
describ
previous
rrtpcr
primer
probe
ha
gene
perform
use
taqman
fast
viru
master
mix
life
technolog
japan
tokyo
japan
accord
manufactur
instruct
thermal
cycl
condit
follow
initi
hold
min
second
cycl
second
second
quantifi
copi
number
eiv
rrtpcr
artifici
rna
synthes
describ
previous
initi
rtpcr
dna
fragment
ha
gene
amplifi
aequin
use
primer
set
describ
newton
et
al
amplifi
product
use
templat
second
pcr
second
pcr
perform
use
modifi
forward
primer
attaaccctcactaaagggagaatgaggtga
contain
promot
sequenc
revers
primer
rna
synthes
use
rna
polymeras
treat
dnase
roch
diagnost
copi
number
rna
calcul
absorb
valu
nm
result
posit
averag
copi
number
exceed
rna
moleculesreact
copiesml
start
sampl
rtloopmedi
isotherm
amplif
rtlamp
conduct
use
loopamp
rna
amplif
kit
eiken
chemic
tokyo
japan
previous
describ
three
test
also
use
determin
detect
limit
mention
averag
detect
period
analys
repeatedmeasur
analysi
varianc
post
hoc
studentnewmankeul
method
use
sigmaplot
systat
softwar
san
jose
ca
usa
level
p
consid
signific
analysi
perform
rad
test
clinic
sampl
sensit
specif
kappa
coeffici
valu
calcul
use
excel
microsoft
japan
tokyo
japan
kappa
coeffici
valu
evalu
accord
guidelin
mention
landi
koch
follow
agreement
slight
fair
moder
substanti
almost
perfect
agreement
use
viral
rna
detect
limit
molecular
test
convent
rtpcr
rrtpcr
rtlamp
eiv
eid
ml
eid
ml
eid
ml
respect
viru
detect
limit
twelv
test
eid
ml
four
sensit
rad
test
prorast
flu
exampl
lesssensit
rad
evalu
ei
experiment
infect
studi
diagnost
sensit
compar
vi
molecular
diagnost
assay
result
obtain
differ
assay
sequenti
sampl
collect
hors
experiment
infect
summar
tabl
averag
detect
period
assay
illustr
figur
mean
durat
day
posit
rrtpcr
result
significantli
longer
rad
test
p
mean
durat
rtlampposit
result
significantli
longer
rad
test
p
except
immunoac
flu
p
quick
chaser
flu
b
p
mean
durat
convent
rtpcrposit
result
significantli
longer
rad
test
p
except
immunoac
flu
p
quick
chaser
flu
b
p
mean
durat
posit
prorast
flu
result
significantli
shorter
test
studi
p
signific
differ
mean
durat
posit
result
obtain
molecular
assay
p
evalu
perform
sensit
rad
test
diagnos
ei
field
sampl
summar
tabl
rrtpcrneg
nasopharyng
sampl
neg
rad
test
rrtpcrposit
sampl
bd
flu
examan
detect
quick
chaser
flu
b
immunoac
flu
detect
posit
esplin
influenza
bn
less
sensit
detect
eight
posit
sampl
kappa
coeffici
valu
indic
substanti
agreement
bd
flu
examan
quick
chaser
flu
b
immunoac
flu
rrtpcr
fair
agreement
esplin
influenza
bn
rrtpcr
rapid
diagnosi
isol
hors
eiv
effect
measur
reduct
diseas
spread
outbreak
isol
radposit
hors
play
key
role
minim
spread
ei
outbreak
japan
rad
test
conduct
use
esplin
influenza
bn
basi
previou
report
indic
compar
sensit
esplin
influenza
bn
bd
directigen
flu
ab
detect
eiv
howev
esplin
influenza
bn
modifi
bd
directigen
flu
ab
replac
new
product
bd
flu
examan
japan
bd
directigen
ez
flu
ab
countri
best
knowledg
studi
first
comprehens
evalu
rad
test
current
market
sakaitagawa
et
al
report
differ
sensit
among
rad
test
detect
avian
likewis
studi
detect
limit
rad
test
evalu
vari
day
sampl
collect
list
first
column
remain
column
list
number
hors
test
posit
assay
fever
andor
nasal
discharg
andor
cough
observ
hors
score
posit
clinic
sign
lowest
viru
titr
viru
isol
log
eid
ml
lowest
rna
copi
number
rrtpcr
copiesml
copiestest
averag
detect
period
day
figur
averag
detect
period
molecular
rad
test
vertic
bar
repres
standard
deviat
although
immunoac
flu
bd
flu
examan
quick
chaser
flu
b
esplin
influenza
bn
show
highest
sensit
detect
limit
eid
ml
among
rad
test
sensit
lower
molecular
diagnos
eid
ml
larg
differ
sensit
rad
test
molecular
test
indic
latter
appropri
test
ei
diagnosi
howev
esplin
influenza
bn
bd
directigen
flu
ab
use
screen
hors
quarantin
station
identif
infect
hors
ei
outbreak
sensit
rad
test
may
serv
adjunct
molecular
test
posit
result
instruct
specif
test
rapid
easi
way
carri
preliminari
screen
ei
suspect
best
use
popul
hors
rather
individu
case
neg
test
result
need
verifi
molecular
test
thu
rad
test
unsuit
test
freedom
infect
prior
movement
decad
rapid
intern
movement
hors
air
increas
risk
viru
incurs
suscept
popul
therefor
detect
eivposit
hors
quarantin
facil
import
control
measur
test
need
optimum
sensit
major
hors
immun
day
shipment
either
primari
cours
booster
thu
like
shed
far
less
viru
hors
experiment
studi
discuss
may
show
clinic
sign
furthermor
quarantin
period
vari
depend
import
countri
purpos
movement
statu
export
countri
thu
window
opportun
detect
ei
may
quit
short
nasal
swab
may
collect
prior
viru
shed
peak
result
suggest
molecular
diagnosi
eiv
like
protect
suscept
local
popul
intrus
eiv
relianc
rad
test
less
sensit
molecular
test
use
studi
rrtpcr
appear
sensit
assay
detect
limit
eid
ml
convert
approx
eid
llreaction
assum
effici
rna
extract
rad
test
enabl
veterinarian
other
respons
health
hors
perform
rapid
diagnosi
ei
without
special
equip
technic
expertis
howev
usag
even
sensit
rad
test
best
limit
popul
screen
neg
sampl
suspect
case
submit
laboratori
test
summari
result
studi
indic
sensit
rad
test
commerci
avail
japan
detect
eiv
vari
huge
moreov
studi
show
three
rad
test
name
immunoac
flu
bd
flu
examan
quick
chaser
flu
b
substanti
fit
diagnos
ei
viral
nucleoprotein
highli
conserv
last
three
decad
amino
acid
homolog
data
shown
eiv
sequenc
divers
affect
sensit
rad
test
howev
test
frequent
modifi
avail
vari
countri
countri
reevalu
perform
may
period
requir
countri
rad
test
necessarili
perform
equin
healthcar
profession
essenti
respons
screen
hors
made
awar
major
test
unsuit
detect
eiinfect
hors
imper
select
appropri
rad
submit
neg
sampl
suspect
case
laboratori
confirmatori
test
